Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models

Under the optimistic assumption of high-prophylactic HPV vaccine coverage, a significant reduction of cancer incidence can only be expected after decades. Thus, immune therapeutic strategies are needed for persistently infected individuals who do not benefit from the prophylactic vaccines. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Venuti, Aldo, Curzio, Gianfranca, Mariani, Luciano, Paolini, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Focussed Research Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554738/
https://www.ncbi.nlm.nih.gov/pubmed/26138695
http://dx.doi.org/10.1007/s00262-015-1734-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554738/
https://www.ncbi.nlm.nih.gov/pubmed/26138695
http://dx.doi.org/10.1007/s00262-015-1734-0

Ejemplares similares